Dual-Cavity Container for Segmented Veterinary Formulations

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current veterinary compositions containing 1-arylpyrazoles and formamidines face challenges with stability and efficacy, particularly in formulations where fipronil and amitraz degrade at physiological pH ranges, leading to short shelf life and inadequate control of fleas and ticks.

Innovation Solution

Formulations combining 1-arylpyrazoles with formamidines in separate carriers, using solvents with specific dielectric constants, and employing dual-cavity containers to maintain stability and enhance synergistic efficacy against ectoparasites.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If 1-arylpyrazoles and formamidines are combined in the same carrier at physiological pH ranges, then synergistic efficacy against parasites is achieved, but stability and shelf life deteriorate due to degradation of fipronil and amitraz

Engineering Contradiction:
Improveefficacy against parasitesVSAvoidstability of formulation
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The formulation is divided into two separate carriers: a first carrier containing the 1-arylpyrazole compound and a second carrier containing the formamidine compound. This segmentation prevents degradation that would occur if both compounds were mixed in the same carrier at physiological pH ranges, while still allowing synergistic efficacy when applied together to the animal.

Inventive Principle:
Principle #1Segmentation

2Stability of the object's composition

If separate carriers are used for 1-arylpyrazoles and formamidines, then stability is improved, but device complexity increases due to dual-cavity container requirements

Engineering Contradiction:
Improvestability of formulationVSAvoidcontainer structure
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

Two separate carriers containing different active ingredients are merged into a single dual-cavity container system. The first carrier with the 1-arylpyrazole compound and the second carrier with the formamidine compound are housed together in one container, maintaining their physical separation for stability while simplifying administration by providing both compounds in a single application unit.

Inventive Principle:
Principle #5Merging (Combining)

3Device complexity

If conventional single-carrier formulations are used, then device complexity is reduced, but duration of action deteriorates due to rapid degradation of active ingredients

Engineering Contradiction:
Improveformulation structureVSAvoidprotection duration
Core Design Contradiction:
Device complexityVSDuration of action of moving object

Solution Approach 1:

The formulation is segmented into two separate carriers within a dual-cavity container, preventing degradation that would occur in a single carrier system. This segmentation allows both active ingredients to remain stable and effective for longer periods, extending the duration of protection against fleas and ticks compared to conventional single-carrier formulations.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS9173728B2Multi-cavity container having offset indentures for dispensing fluids
Publication Date: 2015.11.03 MERIAL LTD
  • US9173728B2 patent drawing
  • US9173728B2 patent drawing
  • US9173728B2 patent drawing

AI summary

Disclosed herein are dual-cavity containers comprising, among other things, a divider wall having a first surface and a second surface opposite the first surface; a first cavity defined by a first wall coupled to the first surface of the divider wall, the first wall having an indenture shaped to conform to a thumb or finger; and a second cavity defined by a second wall and the second surface of the divider wall; the second wall having an indenture shaped to conform to a thumb or finger; and an opening mechanism.